ClinicalTrials.gg
Drug

Bictegravir clinical trials

Also written GS-9883.

studies test it
44
open now
5
in phase 3
16
first study started
2014

Counted the way a researcher would: Bictegravir with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses bictegravir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the bictegravir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
7 Feb 2018 · BIKTARVY · NDA 210251 (FDA, Drugs@FDA; in a combination)
European Union
21 Jun 2018 · Biktarvy · EMEA/H/C/004449 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bictegravir
5
BIC/LEN FDC
2
Bixlenvo™
2

Development codes

GS-9883
3

In one entry with another drug

Given together, or one or the other

B/F/TAF
25
Bictegravir/emtricitabine/tenofovir alafenamide
6
Bictegravir/Lenacapavir (BIC/LEN) FDC
2
BIC/FTC/TAF
2

Studies by the year they started

44 studies that test it; most in 2019 (7)

Studies that test bictegravir, by start year
YearStudies
20141
20156
20161
20171
20186
20197
20205
20214
20222
20231
20244
20251
20265

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
7
Phase 3
16
Phase 4
18
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 24 · Other 20

Gilead Sciences (23) · Shanghai Public Health Clinical Center (1) · Merck Sharp & Dohme LLC (1) · Peking Union Medical College Hospital (1) · Instituto Mexicano del Seguro Social (1) · Midland Research Group, Inc. (1) · Carmen Hidalgo Tenorio (1) · University of Maryland, Baltimore (1)

Often tested with

Tested in the same studies.

Emtricitabine (33) · Tenofovir alafenamide (33) · Lenacapavir (7) · Elvitegravir (2) · Cobicistat (2) · GS-3242 (2) · Dolutegravir (1) · MK4646 (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 6 phase 3 studies under way

Bictegravir is the comparator. A study of two new drugs counts under both.

  • 3Islatravir · Merck Sharp & Dohme LLC · next primary completion Feb 2029
  • 2Lamivudine · ViiV Healthcare, José Antonio Mata Marín · next primary completion Dec 2027
  • 1Dolutegravir · ViiV Healthcare
  • 1Lepetegravir · Gilead Sciences · next primary completion Jan 2028
  • 1Tenofovir · José Antonio Mata Marín · next primary completion Dec 2027
  • 1Ulonivirine · Merck Sharp & Dohme LLC · next primary completion Feb 2029
Reaching primary completion within a year · 2

Studies that test bictegravir.

Studies

Open first, then newest update. How each study uses bictegravir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 44

See all 44 studies that test bictegravir →

Given beside what is tested · 7 — bictegravir is usual care or a partner of the new treatment
As the comparator · 13 — what is tested is compared with bictegravir

Codes

What other systems call bictegravir · ClinicalTrials.gg INT000714

  • MeSH (NLM) C000620396bictegravirOne source NLM
  • UNII (FDA) 8GB79LOJ07BICTEGRAVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 1999660Confirmed FDA, Wikidata
  • Wikidata Q27270406bictegravirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C171719BictegravirOne source FDA
  • DrugBank DB11799One source Wikidata

Also registered as bictegravir sodium (UNII 4L5MP1Y7W7 · RxNorm 1999661).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.